Affinity DataIC50: 4.90nMAssay Description:In vivo inhibition of leutenising hormone in rats.More data for this Ligand-Target Pair
Affinity DataIC50: 6nMAssay Description:Inhibition of human WIL2/dihydrofolate reductase activityMore data for this Ligand-Target Pair
Affinity DataIC50: 6.40nMAssay Description:In vivo inhibition of leutenising hormone in rats.More data for this Ligand-Target Pair
Affinity DataIC50: 7.20nMAssay Description:Inhibition of L1210 leukemia thymidylate synthase (TS) enzymeMore data for this Ligand-Target Pair
Affinity DataIC50: 7.20nMAssay Description:Inhibition of L1210 leukemia thymidylate synthase (TS) enzymeMore data for this Ligand-Target Pair
Affinity DataIC50: 8.30nMAssay Description:In vivo inhibition of leutenising hormone in rats.More data for this Ligand-Target Pair
Affinity DataIC50: 11nMAssay Description:Inhibition of L1210 leukemia thymidylate synthase (TS) enzymeMore data for this Ligand-Target Pair
Affinity DataIC50: 11nMAssay Description:Inhibition of BACE1 (1 to 454 residues) (unknown origin) using APP derived polypeptide harboring Lys-Met/Asn-Leu mutation as substrate by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 12nMAssay Description:Inhibition of human WIL2/dihydrofolate reductase activityMore data for this Ligand-Target Pair
Affinity DataIC50: 12nMAssay Description:Inhibition of L1210 leukemia thymidylate synthase (TS) enzymeMore data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Inhibition of BACE1 in human SKNBE2 cells transfected with APP695 protein assessed as reduction in amyloid beta (1 to 42) levels after 18 hrs by sand...More data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Inhibition of L1210 leukemia thymidylate synthase (TS) enzymeMore data for this Ligand-Target Pair
Affinity DataIC50: 16nMAssay Description:In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaMore data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:In vivo luteinising hormone inhibiting potency in rats is expressed as negative logarithm of the concentration (antagonist)More data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Inhibition of L1210 leukemia thymidylate synthase (TS) enzymeMore data for this Ligand-Target Pair
Affinity DataIC50: 21nMAssay Description:In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaMore data for this Ligand-Target Pair
Affinity DataIC50: 22nMAssay Description:In vivo inhibition of leutenising hormone in rats.More data for this Ligand-Target Pair
Affinity DataIC50: 25nMAssay Description:Inhibition of L1210 leukemia thymidylate synthase (TS) enzymeMore data for this Ligand-Target Pair
Affinity DataIC50: 28nMAssay Description:Inhibition of L1210 leukemia thymidylate synthase (TS) enzymeMore data for this Ligand-Target Pair
Affinity DataIC50: 29nMAssay Description:Inhibition of L1210 leukemia thymidylate synthase (TS) enzymeMore data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:In vivo inhibition of leutenising hormone in rats.More data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:Inhibition of human WIL2/dihydrofolate reductase activityMore data for this Ligand-Target Pair
Affinity DataIC50: 35nMAssay Description:In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaMore data for this Ligand-Target Pair
Affinity DataIC50: 40nMAssay Description:Inhibition of BACE1 in human SKNBE2 cells transfected with APP695 protein assessed as reduction in amyloid beta (1 to 42) levels after 18 hrs by sand...More data for this Ligand-Target Pair
Affinity DataIC50: 41nMAssay Description:Inhibition of human WIL2/dihydrofolate reductase activityMore data for this Ligand-Target Pair
Affinity DataIC50: 49nMAssay Description:In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaMore data for this Ligand-Target Pair
Affinity DataIC50: 115nMAssay Description:In vivo inhibition of leutenising hormone in rats.More data for this Ligand-Target Pair
Affinity DataIC50: 129nMAssay Description:In vivo inhibition of leutenising hormone in rats.More data for this Ligand-Target Pair
Affinity DataIC50: 151nMAssay Description:In vivo inhibition of leutenising hormone in rats.More data for this Ligand-Target Pair
Affinity DataIC50: 251nMAssay Description:Inhibition of BACE1 in human SKNBE2 cells transfected with APP695 protein assessed as reduction in amyloid beta (1 to 42) levels after 18 hrs by sand...More data for this Ligand-Target Pair
Affinity DataIC50: 457nMAssay Description:Inhibition of human WIL2/dihydrofolate reductase activityMore data for this Ligand-Target Pair
Affinity DataIC50: 603nMAssay Description:Inhibition of BACE1 in human SKNBE2 cells transfected with APP695 protein assessed as reduction in amyloid beta (1 to 42) levels after 18 hrs by sand...More data for this Ligand-Target Pair
Affinity DataIC50: 631nMAssay Description:Inhibition of human WIL2/dihydrofolate reductase activityMore data for this Ligand-Target Pair
Affinity DataIC50: 1.86E+3nMAssay Description:Luteinising hormone inhibiting potency in rats is expressed as negative logarithm of the concentration (antagonist)More data for this Ligand-Target Pair
Affinity DataIC50: 2.34E+3nMAssay Description:Inhibition of human WIL2/dihydrofolate reductase activityMore data for this Ligand-Target Pair
Affinity DataIC50: 3.02E+3nMAssay Description:Inhibition of human WIL2/dihydrofolate reductase activityMore data for this Ligand-Target Pair
Affinity DataIC50: 4.50E+3nMAssay Description:In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Janssen Pharmaceutica
Curated by ChEMBL
Janssen Pharmaceutica
Curated by ChEMBL
Affinity DataIC50: 8.00E+3nMAssay Description:In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Janssen Pharmaceutica
Curated by ChEMBL
Janssen Pharmaceutica
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:In vivo inhibition of leutenising hormone in rats.More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+4nMAssay Description:In vivo inhibition of leutenising hormone in rats.More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Janssen Pharmaceutica
Curated by ChEMBL
Janssen Pharmaceutica
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:In vivo inhibition of leutenising hormone in rats.More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Janssen Pharmaceutica
Curated by ChEMBL
Janssen Pharmaceutica
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human ERG expressed in HEK293 cell membranes by radioligand binding assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Janssen Pharmaceutica
Curated by ChEMBL
Janssen Pharmaceutica
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human ERG expressed in HEK293 cell membranes by radioligand binding assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Janssen Pharmaceutica
Curated by ChEMBL
Janssen Pharmaceutica
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Janssen Pharmaceutica
Curated by ChEMBL
Janssen Pharmaceutica
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human ERG expressed in HEK293 cell membranes by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: >3.00E+4nMAssay Description:In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaMore data for this Ligand-Target Pair
Affinity DataIC50: >3.00E+4nMAssay Description:In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaMore data for this Ligand-Target Pair
Affinity DataIC50: >3.00E+4nMAssay Description:In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaMore data for this Ligand-Target Pair
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of human WIL2/dihydrofolate reductase activityMore data for this Ligand-Target Pair
Affinity DataIC50: >3.00E+4nMAssay Description:In vivo inhibition of leutenising hormone in rats.More data for this Ligand-Target Pair